Table 1 Admission Blood Counts and Liver Function Testing
From: Pembrolizumab-induced Hemophagocytic Lymphohistiocytosis: an immunotherapeutic challenge
| Admission | 3 weeks prior to admission | Normal range | |
|---|---|---|---|
| White Blood Cell (WBC) | 3.37 | 6.69 | 4.8–10.8 K/cumm |
| Hemoglobin | 9.5 | 12.6 | 14–18 g/dL |
| Platelets | 32 | 195 | 140–440 K/cumm |
| Aspartate Aminotransferase (AST) | 289 | 20 | 5–34 U/L |
| Alanine Aminotransferase (ALT) | 474 | 20 | 5–45 U/L |
| Alkaline Phosphatase (ALP) | 474 | 76 | 35–150 U/L |
| Total Bilirubin | 1.8 | 0.5 | 0.2–1.2 mg/dL |